Loading...
Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy
Chronic myeloid leukemia and systemic mastocytosis are myeloid neoplasms sharing a number of pathogenetic and clinical features. In both conditions, an aberrantly activated oncoprotein with tyrosine kinase activity, namely BCR-ABL1 in chronic myeloid leukemia, and mutant KIT, mostly KIT D816V, in sy...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ferrata Storti Foundation
2014
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3943304/ https://ncbi.nlm.nih.gov/pubmed/24598853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.098442 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|